Evidence map›Paper›PMID 35418346›Full record

ArticleEuropean journal of internal medicine2022

Echocardiographic markers of early alcoholic cardiomyopathy: Six-month longitudinal study in heavy drinking patients.

Antonio Mirijello, Luisa Sestito, Christian Lauria, Claudia Tarli, Gabriele Angelo Vassallo, Mariangela Antonelli, Cristina d'Angelo, Anna Ferrulli, Filippo Crea, Anthony Cossari and 4 more

Open access · greenAbstract read
In one paragraph

Article in European journal of internal medicine, 2022. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 6 papers.

0numbers the graph read from it
0cells of the map it votes in
6citing papers in PubMed
2.3field-weighted citation impact, top 11% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

6 citing papers in PubMed, 15 citations in OpenAlex.

  1. Observational
  2. Article
  3. Article
  4. Article
  5. Article
  6. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

14 authors at 7 institutions in 2 countries.

Antonio MirijelloDepartment of Medical Sciences, IRCCS Casa Sollievo della Sofferenza, v.le Cappuccini, San Giovanni Rotondo 71013, Italy. Electronic address: a.mirijello@operapadrepio.it.
Luisa SestitoDepartment of Medical Sciences, Hepatology and Gastroenterology Unit, Catholic University of Rome, l.go Gemelli, 8, Rome 00168, Italy.
Christian LauriaDepartment of Cardiovascular Sciences, Catholic University of Rome, Italy.
Claudia TarliDepartment of Medical Sciences, Hepatology and Gastroenterology Unit, Catholic University of Rome, l.go Gemelli, 8, Rome 00168, Italy.
Gabriele Angelo VassalloDepartment of Internal Medicine, Barone Lombardo Hospital, Canicattì, Italy.
Mariangela AntonelliDepartment of Medical Sciences, Hepatology and Gastroenterology Unit, Catholic University of Rome, l.go Gemelli, 8, Rome 00168, Italy.
Cristina d'Angelo"Gli Angeli di Padre Pio", Padre Pio Rehabilitation Centres Foundation, San Giovanni Rotondo, Italy.
Anna FerrulliDepartment of Biomedical Sciences for Health, Università degli Studi di Milano, Milan, Italy; Department of Endocrinology, Nutrition and Metabolic Diseases, IRCCS MultiMedica, Sesto San Giovanni, Milan, Italy.
Filippo CreaDepartment of Cardiovascular Sciences, Catholic University of Rome, Italy.
Anthony CossariDepartment of Economics, Statistics and Finance "Giovanni Anania", University of Calabria, Rende 87036, Italy.
Lorenzo LeggioClinical Psychoneuroendocrinology and Neuropsychopharmacology Section, Translational Addiction Medicine Branch, National Institute on Drug Abuse Intramural Research Program and National Institute on Alcohol Abuse and Alcoholism Division of Intramural Clinical and Biological Research, National Institutes of Health, Bethesda, Baltimore, MD, United States; Medication Development Program, National Institute on Drug Abuse Intramural Research Program, National Institutes of Health, Baltimore, MD, United States; Center for Alcohol and Addiction Studies, Department of Behavioral and Social Sciences, School of Public Health, Brown University, Providence, RI, United States; Division of Addiction Medicine, Department of Medicine, School of Medicine, Johns Hopkins University, Baltimore, MD, United States; Department of Neuroscience, Georgetown University Medical Center, Washington DC, United States.
Salvatore De CosmoDepartment of Medical Sciences, IRCCS Casa Sollievo della Sofferenza, v.le Cappuccini, San Giovanni Rotondo 71013, Italy.
Antonio GasbarriniDepartment of Medical Sciences, Hepatology and Gastroenterology Unit, Catholic University of Rome, l.go Gemelli, 8, Rome 00168, Italy.
Giovanni AddoloratoDepartment of Medical Sciences, Hepatology and Gastroenterology Unit, Catholic University of Rome, l.go Gemelli, 8, Rome 00168, Italy. Electronic address: giovanni.addolorato@unicatt.it.
Agostino Gemelli University Polyclinic · ITCasa Sollievo della Sofferenza · ITUniversità Cattolica del Sacro Cuore · ITNational Institutes of Health · USOspedale dei Pellegrini · ITUniversity of Calabria · ITUniversity of Milan · IT

Funding

Clinical Psychoneuroendocrinology and Neuropsychopharmacology (CPN)ZIADA000635 · NIDA · NATIONAL INSTITUTE ON DRUG ABUSE · PI LEGGIO, LORENZO · 2020 to 2025
$15.2M
Intramural NIH HHS ZIA DA000635
6 · The paper itself

Abstract

backgroundThe development of alcoholic cardiomyopathy (ACM) is related to chronic excessive alcohol use. However, features of early-stage ACM are still unclear. We assessed echocardiographic characteristics of patients with alcohol dependence (DSM-IV criteria) during a six-month treatment period.

methodsActive drinking patients, heavy alcohol users, without heart disease, referred to our Alcohol Addiction Unit were enrolled in the study. After signing informed consent, patients started outpatient treatment program. Echocardiography was performed at enrollment, then three and six months afterwards, by cardiologists blinded to drinking status.

resultsForty-three patients (36 males, 7 females) were enrolled. At six months, 20 patients (46.5%) reduced alcohol consumption below heavy drinking levels. Although within normal range, baseline mean IVS thickness and mean LVDD were significantly higher (p < 0.001) and mean EF significantly reduced (p = 0.009), as compared to age-matched mean references. Mean E/A ratio, DcT and LA diameter were significantly different (p < 0.001) from mean references, but within normal range. Baseline mean E/e' ratio was significantly higher than the mean reference (p < 0.001) and out of the normal range. A significant correlation between the number of drinks per drinking days in the 7 days before baseline assessment and E/e' ratio was observed (p = 0.028). After six months, a trend-level reduction of mean E/e' ratio (p = 0.051) was found in the whole sample; this reduction was statistically significant (p = 0.041) among patients reducing drinking, compared to baseline.

conclusionsAltered E/e' ratio may characterize early-ACM before the occurrence of relevant echocardiographic alterations. The reduction of alcohol consumption could restore this alteration after six months.

Indexed as

Cardiomyopathy, AlcoholicVentricular Dysfunction, LeftBiomarkersEchocardiographyFemaleHumansLongitudinal StudiesMaleVentricular Function, LeftBiomarkersAlcohol dependenceAlcohol use disordersDiastolic dysfunctionHeart failureLeft ventricular filling pressure

Identifiers

PMID35418346
PMCPMC9233051
OpenAlexW4223464427

What OpenQuestion holds

Textmetadata
LicenceTDM
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.